-transparent.png){kind=logo}
Osteoporosis is a common skeletal disease with serious clinical consequences because of fractures. Despite the availability of clinical tools to diagnose osteoporosis and assess fracture risk, and drugs proven to reduce fracture risk, it remains a disease that is underdiagnosed and undertreated. When treatment is started, it is commonly not taken correctly or long enough to be effective. Recent advances in understanding of the regulators and mediators of bone remodeling have led to new therapeutic targets and the development of drugs that may offer advantages over current agents in reducing the burden of osteoporotic fractures. Many genetic factors that play a role in the pathogenesis of osteoporosis and metabolic bone disease have now been identified. At the 2009 Santa Fe Bone Symposium, held in Santa Fe, New Mexico, USA, the links between advances in genetics, basic bone science, recent clinical trials, and new and emerging therapeutic agents were presented and explored. Socioeconomic challenges and opportunities in the care of osteoporosis were discussed. This is a collection of medical essays based on key presentations at the 2009 Santa Fe Bone Symposium.
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
November 2006,
Women's health (London, England),
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
September 2007,
EMBO reports,
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
May 2021,
Scientific data,
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
January 2010,
Midwifery today with international midwife,
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
May 2013,
Revista panamericana de salud publica = Pan American journal of public health,
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
January 1995,
Journal of cellular biochemistry. Supplement,
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
December 2008,
Behavioral healthcare,
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
January 1993,
Science (New York, N.Y.),
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
April 1978,
Architectural record,
E Michael Lewiecki, and
John P Bilezikian, and
Andrew J Laster, and
Paul D Miller, and
Robert R Recker, and
R Graham G Russell, and
Michael P Whyte
January 1954,
Hospital progress,
